What’s hot at APS & MCV 2025? | Multidisciplinary

MIMS Doctor brings you extensive coverage of the Asia Pneumonia Summit & MasterClass in Vaccinology 2025, held recently in Taipei, Taiwan. Check out the latest updates on RSV, pneumococcal disease, new vaccines, plus thought-provoking insights from respiratory experts. [READ THE FULL REPORT]

Hot topics you should not miss:

Vaccine hesitancy cuts children’s lives short

Decline in IPD incidence in Taiwan

Vaccines not just for kids, crucial for older adults, too

RSV in older adults: An overlooked threat

RSV places a substantial burden on infants, the elderly

RSVpreF vaccination during pregnancy protects babies against RSV

PCV20 simplifies immunization strategies against pneumococcal diseases

Lessons learned from PCVs: Expect the unexpected

Serotype distribution & IPD prevention in children in APAC

*This coverage of the APS & MCV 2025 Conference has been prepared by MIMS, commissioned by Pfizer Medical, to summarise the event. Pfizer has only reviewed the content to ensure it meets specific Pfizer standards, but has not verified the accuracy of the content, references, medical information, facts, and opinions provided. Any medical information, facts, views, opinions, and thoughts expressed in this content are solely those of the speakers and do not necessarily reflect or represent the views of, and are not attributable to, Pfizer and/or its affiliates.

FOR HEALTHCARE PROFESSIONALS ONLY

Resources

Asia Pneumonia Summit & MasterClass in Vaccinology 2025